arrow
R

Robert Tauber

technical university of munich
H指数:32
被引数:4,516

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessment of nephrotoxicity following lutetium-177 PSMA I&T radioligand therapy: a comparative study with docetaxel chemotherapy

评估177Lu-PSMA I&T放射性配体治疗后肾毒性的评估:与多西他赛化疗的对比研究

2026-04-160
OA
[68Ga]Ga-PSMA-11 PET Tumor Volume Predicts Overall Survival of Patients with Metastatic Prostate Cancer Undergoing Taxane-Based Chemotherapy

[(68)Ga]Ga-PSMA-11 PET肿瘤体积可预测接受紫杉烷类化疗的转移性前列腺癌患者的总生存期

2025-11-011
PRE
Impact of baseline 18F-flotufolastat PET bone tumor volume for prognosticating severe hematologic toxicity in patients with metastatic castration-resistant prostate Cancer receiving 177Lu-PSMA-targeted radioligand therapy

基线18F-flotufolastat PET骨肿瘤体积对接受177Lu-PSMA靶向放射性配体治疗转移性去势抵抗性前列腺癌患者严重血液学毒性的预后评估影响

2025-05-190
OA
Automated CT Measurement of Total Kidney Volume for Predicting Renal Function Decline after 177Lu Prostate-specific Membrane Antigen-I&T Radioligand Therapy

177Lu Prostate-specific Membrane Antigen-I&T 放射配体治疗后肾总容积的自动CT测量及其对肾功能下降的预测

RADIOLOGY
IF15.2
2025-02-011
PRE
Long-Term Nephrotoxicity of 177Lu-PSMA Radioligand Therapy

177Lu-PSMA放射性配体治疗的长期肾毒性

2023-10-1913
OA
Hsp70-A Universal Biomarker for Predicting Therapeutic Failure in Human Female Cancers and a Target for CTC Isolation in Advanced Cancers
2023-08-166
OAAI
Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study
2022-04-1492
OAAI